
Ils Foundation
About Ils Foundation
Data last updated:
Ils Foundation is a private not for profit company based in New Delhi, Delhi, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 13 April 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U85100DL2015NPL278960.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neeraj Gupta and Ritu Gupta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
As per the financials filed for FY 2025, the company reported a revenue of ₹26.15 Lakh, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹16.01 Lakh (net margin 61.2%) and EBITDA of ₹16.01 Lakh (EBITDA margin 61.2%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Ils Foundation's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Ils Foundation, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Ils Foundation
FY 2025 filings availableIls Foundation reported revenue of ₹26.15 Lakh (up 56% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years, including 56% growth in the latest year. EBITDA rose 531% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹16.01 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹16.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 61.2% | ||||
| Net Profit Margin | 61.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ils Foundation, buy the company report.
Board of directors of Ils Foundation
Ils Foundation has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Gupta | Director | 13 Apr 2015 | 11 Years 7 Months | Current |
| Ritu Gupta Also directs: Imperial Life Sciences Private Limited, Genes 2Me Private Limited | Director | 05 Dec 2024 | 1 Years 11 Months | Current |
Peer comparison
Ils Foundation is compared with the 10 companies closest to it by revenue in the Pharma industry (Contract Research), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Syntegrity Labs Private Limited | ₹26.68 Lakh (FY 2021) | 43.0% | Hosur, Tamil Nadu, India | |||
| A P S Medical and Research Centre Pvt Ltd | ₹26.6 Lakh (FY 2024) | 12.0% | Delhi, India | |||
| Indya Clinical Research Private Limited | ₹26.49 Lakh (FY 2025) | -75.0% | Bangalore, Karnataka, India | |||
| Synthetic Research Pharma Laboratories Private Limited | ₹26.32 Lakh (FY 2025) | 148.0% | Hyderabad, Telangana, India | |||
| Poullac Pharmaceuticals Private Limited | ₹26.25 Lakh (FY 2025) | -77.0% | Saharanpur, Uttar Pradesh, India | |||
| Ils Foundationthis company | ₹26.15 Lakh (FY 2025) | ₹16.01 Lakh | 61.2% | 56.0% | New Delhi, Delhi, India | |
| Natural Elements Foundation | ₹26.14 Lakh (FY 2025) | 27.0% | Gurgaon, Haryana, India | |||
| Nucleon Research Private Limited | ₹26.1 Lakh (FY 2025) | Mumbai, Maharashtra, India | ||||
| Crmo Pharmatech Private Limited | ₹24.57 Lakh (FY 2025) | -28.0% | Gandhinagar, Gujarat, India | |||
| Huda Medi Research Private Limited | ₹24.43 Lakh (FY 2025) | 132.0% | Pune, Maharashtra, India | |||
| Ileads Therapeuircs Private Limited | ₹24.42 Lakh (FY 2024) | -2.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Ils Foundation, buy the company report.
Auditor
Ils Foundation is audited by K S BAWA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K S BAWA & ASSOCIATES | FY 2018 | 003979N |
Shareholding
The shareholding of Ils Foundation is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ils Foundation, buy the company report.
Legal cases
No court or tribunal cases involving Ils Foundation are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ils Foundation; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Ils Foundation; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ils Foundation has 3 board changes on record since 2015: 2 appointments and 1 cessation. The latest: Suresh Kumar Gupta ceased to be Director on 06 Dec 2024.
Frequently asked questions
Ils Foundation is an active private not for profit company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 13 April 2015 (11+ years old) and is registered under CIN U85100DL2015NPL278960.
Ils Foundation has 2 current directors:
- Neeraj Gupta - Director
- Ritu Gupta - Director
The latest financial statements of Ils Foundation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Ils Foundation is U85100DL2015NPL278960. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ils Foundation was incorporated on 13 April 2015, making it 11+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Ils Foundation by revenue are Syntegrity Labs Private Limited, A P S Medical and Research Centre Pvt Ltd, Indya Clinical Research Private Limited, Synthetic Research Pharma Laboratories Private Limited, Poullac Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Contract Research).
Suresh Kumar Gupta ceased to be Director on 06 Dec 2024. Ritu Gupta was appointed as Director on 05 Dec 2024. Neeraj Gupta was appointed as Director on 13 Apr 2015.
The registered office of Ils Foundation is at Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.
Ils Foundation operates in the pharma industry, in the pharma contract r and d segment.
The compliance status of Ils Foundation is compliant as of 06 August 2026. The company is actively filing with the Registrar of Companies.
Ils Foundation can be reached at its registered office: Flat No. 234 Somdutt Chamber – II 9 Bhikaji Cama Place, New Delhi, Delhi, India – 110066.

